Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial)

Overview of attention for article published in Urologic Oncology, May 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 35,742 followers.

RT @ZakhariaYousef: Early phase IIT to suggest favorable outcome with Taxol/CPI in UC. Kudos to @RohanGarjeMD for putting this IIT as 3rd y…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.